Skip to content

Company

Entrada Therapeutics

United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Entrada Therapeutics?

Held by 42 covered funds. Sorted by Entrada Therapeutics’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
IBRNiShares Neuroscience and Healthcare0.2%
HAPSHarbor Human Capital Factor US Small Cap0.1%
NOSGXSmall Cap Value Fund0.0%
IWCiShares Micro-Cap0.0%
IBBQInvesco Nasdaq Biotechnology0.0%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.0%
AVSCAvantis U.S. Small Cap Equity0.0%
AVSCXAvantis U.S. Small Cap Equity Fund0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
IWNiShares Russell 2000 Value0.0%
GSSCGoldman Sachs ActiveBeta(R) U.S. Small Cap Equity0.0%
VTWVVanguard Russell 2000 Value Index Fund0.0%
IBBiShares Biotechnology0.0%
NSIDXSmall Cap Index Fund0.0%
IWMiShares Russell 20000.0%
RSSLGlobal X Russell 20000.0%
VTWOVanguard Russell 2000 Index Fund0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
ITWOProShares Russell 2000 High Income0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
DFASDimensional U.S. Small Cap0.0%
DXUVDimensional US Vector Equity0.0%
SCHASchwab U.S. Small-Cap0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
VHTVanguard Health Care Index Fund0.0%
VXFVanguard Extended Market Index Fund0.0%
AVSUAvantis Responsible U.S. Equity0.0%
DFSVDimensional US Small Cap Value0.0%
DCORDimensional US Core Equity 10.0%
DFSUDimensional US Sustainability Core 10.0%
MSSMMorgan Stanley Pathway Small-Mid Cap Equity0.0%
AVUNXAvantis U.S. Equity Fund0.0%
AVUSAvantis U.S. Equity0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
DFAUDimensional US Core Equity Market0.0%
IWViShares Russell 30000.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
SCHBSchwab U.S. Broad Market0.0%
VTIVanguard Total Stock Market Index Fund0.0%
SSBIXState Street Balanced Index Fund0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
DFACDimensional U.S. Core Equity 20.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Entrada Therapeutics news

No recent stories about Entrada Therapeutics.